Supplemental Figure

Total Page:16

File Type:pdf, Size:1020Kb

Supplemental Figure ● Agonist ● Antagonist ● Interference AR AUC 0.0 0.2 0.4 0.6 0.8 1.0 1.2 1.4 1.6 17beta−Trenbolone 5alpha−Dihydrotestosterone 17−Methyltestosterone Testosterone propionate Norethindrone Norgestrel GSK232420A 4−Androstene−3,17−dione Progesterone 17beta−Estradiol Mifepristone 17alpha−Ethinylestradiol Hydroxyflutamide 17alpha−Hydroxyprogesterone Corticosterone Nilutamide Basic Blue 7 Triphenyltin hydroxide Bicalutamide Tributyltin benzoate 17alpha−Estradiol Gentian Violet Equilin Zinc pyrithione Triticonazole Fenitrothion Mestranol Tributyltin methacrylate 2,2−Bis(4−hydroxyphenyl)−1,1,1 Dibutyltin dichloride Flutamide Methyltrioctylammonium chlorid Rhodamine 6G Tributyltetradecylphosphonium Emamectin benzoate Phenylmercuric acetate Cyproterone acetate Chlorothalonil 9−Phenanthrol 2,2',4,4'−Tetrahydroxybenzophe Melengestrol acetate Dehydroepiandrosterone 1−Chloro−2,4−dinitrobenzene SSR240612 Methylbenzethonium chloride Vinclozolin Tetraconazole Ziram Didecyldimethylammonium chlori Econazole nitrate Myristyltrimethylammonium chlo Clorophene Abamectin Octyl gallate 2−Chloro−4−phenylphenol Bisphenol A Propanil Dexamethasone sodium phosphate meso−Hexestrol Dichlorophen Hydroxyprogesterone caproate SSR241586 Bisphenol AF Prednisone Dichlone Reserpine Chlorobenzilate Diethylstilbestrol 3−Hydroxyfluorene Procymidone 4−Cumylphenol 4−Hydroxytamoxifen Napropamide PharmaGSID_48519 Clomiphene citrate (1:1) Chlorhexidine diacetate Tebuconazole Imazalil Dinocap PharmaGSID_48513 Linuron Prochloraz Zoxamide TDCPP Captan 3,3'−Dimethoxybenzidine dihydr 4−Phenylphenol Captafol Estrone Tetrabutyltin SB236057A Triclosan PharmaGSID_48510 Milbemectin (mixture of 70% Mi Ipconazole Kepone GSK163929B Dodecyltrimethylammonium chlor Bisphenol B p,p'−DDE 2,2'−(Tetradecylimino)diethano Benzalkonium chloride Diazolidinyl urea Flusilazole Bromuconazole PD 0343701 4,4',4"−Ethane−1,1,1−triyltrip Methylene blue Dimethomorph Hydramethylnon 2,2'−Methylenebis(4−methyl−6−t Bromophenol blue Hexadecyltrimethylammonium bro Hexaconazole 4−(1,1,3,3−Tetramethylbutyl)ph 4−Nonylphenol, branched Tributyltin chloride Nordihydroguaiaretic acid PharmaGSID_47315 SSR126768 Raloxifene hydrochloride 2,2'−Methylenebis(ethyl−6−tert Cycloheximide Fenhexamid 4,4'−Sulfonylbis[2−(prop−2−en− Metconazole Triflumizole Acibenzolar−S−methyl FD&C Green No. 3 2,4−Dihydroxybenzophenone Farglitazar Estriol 1,4−Dihydroxy−2−naphthoic acid Rotenone Ketoconazole Chlorophacinone 1−Phenyl−1H−pyrrole−2,5−dione Dodecylphenol SAR102779 4−Dodecylphenol Polyoxyethylene(10)nonylphenyl Tris(2,3−dibromopropyl) phosph Octhilinone Fluorescein Spironolactone Amiodarone hydrochloride Propargite Triamcinolone Diniconazole 6−Hydroxy−2−naphthyl disulfide PharmaGSID_48506 Dodecyl gallate SSR504734 Azinphos−methyl AVE6324 Phenolphthalein Methyl linoleate 2−Amino−5−azotoluene Prallethrin Eosin SAR150640 Propiconazole 2,4−Bis(1−methyl−1−phenylethyl Difenoconazole MK−968 Oxazepam Bromocriptine mesylate Apigenin Fluazinam 4−Nitrosodiphenylamine Methyl parathion 3,3'−Dimethylbenzidine dihydro 1,2−Dibromo−2,4−dicyanobutane o,p'−DDT 7,12−Dimethylbenz(a)anthracene CP−122721 Resmethrin 2−Ethylhexylparaben (2−Nitro−1−propenyl)benzene Darbufelone mesylate Dodecyl sulfate triethanolamin Tannic acid Parathion Oryzalin PharmaGSID_48505 1−Hydroxypyrene CP−607366 Butachlor Folpet 2−Chloro−N−phenylacetamide FR150011 Acetochlor Nitrofen UK−373911 Fenbuconazole Monotridecyl phosphate 4−Hexylresorcinol Disulfiram Fenthion Docusate sodium 1,2−Benzisothiazolin−3−one Clomazone Elzasonan 5HPP−33 Fabesetron hydrochloride Fandosentan potassium salt AVE5638 4,5−Dichloro−3H−1,2−dithiol−3− 3−Iodo−2−propynyl−N−butylcarba Chlorfenapyr S−Bioallethrin Alachlor Laurocapram 3,3'−Dimethylbenzidine FD&C Blue No. 1 Prodiamine Polyoxyethylene monoleate 3,3',5,5'−Tetrabromobisphenol Methylene bis(thiocyanate) PharmaGSID_48511 Fulvestrant Fluoranthene MK−274 p,p'−DDD Fenpyroximate (Z,E) Dicloran Endothal Chlordane 4,5−Dichloro−2−octyl−3(2H)−iso MGK−264 Chlorpromazine hydrochloride SSR103800 Ergocalciferol 7−(Dimethylamino)−4−methylcoum Auramine hydrochloride Disodium 4,4'−bis(2−sulfostyry Diallyl phthalate SAR115740 Michler's ketone o,p'−DDD 2−(8−Heptadecenyl)−2−imidazoli Etoxazole Pendimethalin Dicofol SR271425 Bisphenol F Allethrin Fenoxycarb Disiquonium chloride Temephos Tebufenpyrad Dicyclohexyl phthalate Carbosulfan Celecoxib Endosulfan Thiram (2R,6S)−Fenpropimorph Benzyl−C8−18−alkyldimethylammo 4−(Hexyloxy)phenol C.I. Direct Yellow 12 Clotrimazole Tamoxifen citrate 3,9−Epoxy−3H−azirino[2,3−c][1] UK−337312 3,3'−Dimethoxybenzidine Diphenylmercury(II) SR146131 Propachlor Hexachlorocyclopentadiene 1,2−Dinitrobenzene 4,4'−Dithiodimorpholine 4,4'−Methylenebis(2−methylanil Calcium dodecylbenzene sulfona Ethyl (2E,4Z)−deca−2,4−dienoat Chlorpropham Mercuric chloride Nelivaptan Lovastatin Retinol acetate Cyhalofop−butyl p,p'−DDT CP−100829 Isopropalin Fipronil SR125047 Dimethyltin dichloride Apomorphine hydrochloride hydr Bis(2−ethylhexyl) phosphate Heptachlor epoxide 4,4'−Methylenebis(2,6−diethyla PK 11195 Azoxystrobin 1,3−Diphenylguanidine Retinol Tiratricol Chlorpyrifos oxon Pyridaben Fenofibrate Glutaraldehyde Surinabant Buprofezin Mancozeb Silwet L77 4−Cyclohexylcyclohexanol Bensulide 1,2−Benzenedicarboxaldehyde Tris(2−ethylhexyl) phosphate Dazomet Tetramethrin 2,4−Di−tert−butylphenol 4−Nonylphenol Atorvastatin calcium 1,2,5,6,9,10−Hexabromocyclodod 1−Decanamine Fenarimol Triphenylethylene Methoxychlor Heptachlor Dinoseb PharmaGSID_47337 Rhodamine B Tamoxifen Dieldrin 2,5−Di−tert−butylbenzene−1,4−d Farnesol 2,4,5−Trichlorophenol 2−Chloroacetophenone 4−Chloro−1,2−diaminobenzene Naled Aplaviroc hydrochloride Phosalone Fluoxastrobin Methyl red Triphenyl phosphate Oxadiazon Ro 23−7637 Coumaphos Troglitazone PharmaGSID_47330 Cyazofamid Aldrin Chloroallyl methenamine chlori CP−401387 Quinoxyfen UK−416244 FR167356 CP−728663 CP−085958 Z−Tetrachlorvinphos Azamethiphos 2−Methyl−4,6−dinitrophenol Trelanserin Codlelure C.I. Disperse Orange 37 PharmaGSID_48172 N−Phenyl−1−naphthylamine Ethalfluralin Amitraz Hexythiazox Digoxin Triclocarban CJ−013790 Bisphenol A diglycidyl ether CP−105696 Epoxiconazole Formamide Profenofos 2,2',6,6'−Tetrachlorobisphenol Endosulfan I Triglycidyl isocyanurate 2−Aminoanthraquinone Ingliforib PFOSA Bifenthrin N−(Cyclohexylthio)phthalimide Tricresyl phosphate Simvastatin tert−Butylhydroquinone 2−Hydroxybenzonitrile 1−Tetradecanol SSR161421 1−Dodecyl−2−pyrrolidinone Maneb Di(propylene glycol) dibenzoat Linoleic acid Tri−allate Dodecylbenzenesulfonic acid Linolenic acid 1,4−Diaminoanthraquinone SSR150106 Sodium myristyl sulfate C.I. Acid Red 114 Sodium (2−pyridylthio)−N−oxide Picoxystrobin PharmaGSID_47333 Fludioxonil Fenamidone CJ−013610 1,10−Phenanthroline Famoxadone SB243213A SSR69071 Enterolactone Ranitidine 2−Nitrotoluene Ethion Trifloxystrobin PFOS FD&C Red 3 1−Tridecanol 4−Methylstyrene Dimethyl methylphosphonate 1−Dodecanamine m−Xylene PharmaGSID_47263 Indoxacarb 4−Hexylaniline Oleyl sarcosine 4−tert−Butyltoluene 2,6,10−Trimethyl−2,6,10−triaza Silica (−)−alpha−Pinene Sodium ethasulfate 1−(6−tert−Butyl−1,1−dimethyl−2 Sodium tridecyl sulfate Sodium dodecyl sulfate C.I. Acid Orange 8, monosodium Oxytetracycline dihydrate Sodium lauryl polyoxyethylene C.I. Acid Orange 7 Sodium 4−octylbenzenesulfonate Sulfasalazine Bromoxynil Dodecylbenzene sulfonate triet Sodium dodecylbenzenesulfonate Decanal Hexyl benzoate 2,3−Dihydro−2,2−dimethyl−7−ben Arabinose 2,4−Diisopropylphenol (+/−)−alpha−Methylbenzyl aceta (−)−beta−Pinene (2−Dodecenyl)succinic anhydrid (2E)−2−Hexenal (2E)−3−Phenylprop−2−enal (2Z)−3,7−Dimethylocta−2,6−dien (3,5−Dimethyl−1H−pyrazol−1−yl) (3Z)−3−Hexenyl acetate (4Z)−4−Decenal (9Z,12R)−12−Hydroxyoctadec−9−e (Dicyclopentadienyloxy)ethyl m (E)−1,2−Dichloroethylene (E)−Anethole (Methylcyclopentadienyl)tricar (S)−(−)−beta−Citronellol (Z)−11−Hexadecenal (Z)−3−Hexen−1−ol 1,1,1,3,5,5,5−Heptamethyltrisi 1,1,2,2−Tetrahydroperfluoro−1− 1,1−Bis(3,4−dimethylphenyl)eth 1,1−Dimethyl−2−phenylethyl but 1,1−Dimethylhydrazine 1,2,3,6−Tetrahydrophthalimide 1,2,3−Benzotriazole 1,2,3−Trichlorobenzene 1,2,3−Trichloropropane 1,2,4,5−Tetrachlorobenzene 1,2,4,5−Tetramethylbenzene 1,2,4−Trichlorobenzene 1,2,4−Trimethylbenzene 1,2−Benzenedicarboxylic acid, 1,2−Dibromoethane 1,2−Dichloro−4−(trifluoromethy 1,2−Dichlorobenzene 1,2−Dimethyl−3−nitrobenzene 1,2−Dimethyl−4−nitrobenzene 1,2−Diphenoxyethane 1,2−Diphenylethanone 1,2−Diphenylhydrazine 1,2−Ethanediamine dihydriodide 1,2−Ethanediol diacetate 1,2−Phenylenediamine 1,2−Propylene glycol 1,3,5,7−Tetramethyl−1,3,5,7−te 1,3,5−Triethylhexahydro−s−tria 1,3,5−Triisopropylbenzene 1,3,5−Trimethylbenzene 1,3−Benzenediamine 1,3−Benzenedicarbonyl dichlori 1,3−Benzenedicarboxylic acid 1,3−Benzenedimethanamine 1,3−Butanediol 1,3−Butyleneglycol dimethacryl 1,3−Cyclopentadiene 1,3−Dibromo−5,5−dimethylhydant 1,3−Dichloro−2−propanol 1,3−Dichloro−5,5−dimethylhydan 1,3−Dichlorobenzene 1,3−Diisopropylbenzene 1,3−Dimethyl−4−nitrobenzene 1,3−Dinitrobenzene 1,3−Diphenyl−1,3−propanedione 1,3−Divinyl−1,1,3,3−tetramethy 1,3−Propane sultone 1,4−Benzenediamine 1,4−Bis(N−isopropylamino)anthr 1,4−Butanediol 1,4−Cyclohexanedicarboxylic ac 1,4−Dichlorobenzene 1,4−Dimethylnaphthalene 1,4−Heptanolide 1,5,9−Cyclododecatriene 1,5−Naphthalenediamine 1,6−Diisocyanatohexane 1,6−Hexanediamine 1,8−Cineol 1−(2−Aminoethyl)piperazine 1−(Bromomethyl)−3−phenoxybenze 1−(Hydroxymethyl)−5,5−dimethyl 1−Amino−2−propanol 1−Benzylquinolinium chloride 1−Bromo−4−fluorobenzene 1−Cedr−8−en−9−ylethanone 1−Chloro−4−(trifluoromethyl)be 1−Chloro−4−nitrobenzene 1−Decanol
Recommended publications
  • 36Th ITC Report
    Thursday August 17, 1995 Part V Environmental Protection Agency Thirty-Sixth Report of the TSCA Interagency Testing Committee to the Administrator; Receipt of Report, Request for Comments, Solicitation of Use and Exposure Data; Notice federal register 42981 42982 Federal Register / Vol. 60, No. 159 / Thursday, August 17, 1995 / Notices ENVIRONMENTAL PROTECTION comments and data in electronic form ``OPPTS±41043'' (including comments AGENCY must be identified by the docket number and data submitted electronically as OPPT±41043. No CBI should be described below). A public version of [OPPTS±41043; FRL±4965±6] submitted through e-mail. Electronic this record, including printed, paper Thirty-Sixth Report of the TSCA comments on this notice may be filed versions of electronic comments, which Interagency Testing Committee to the online at many Federal Depository does not include any information Administrator; Receipt of Report, Libraries. Additional information on claimed as confidential business Request for Comments, Solicitation of electronic submissions can be found in information (CBI), is available for Use and Exposure Data Unit III of this document. inspection from 12 noon to 4 p.m., FOR FURTHER INFORMATION CONTACT: Monday through Friday, excluding legal AGENCY: Environmental Protection Susan B. Hazen, Director, holidays. The public record is located in Agency (EPA). Environmental Assistance Division the TSCA Nonconfidential Information ACTION: Notice. (7408), Office of Pollution Prevention Center, Rm. NE-B607, 401 M St., SW., and Toxics, Environmental Protection Washington, DC 20460. SUMMARY: The TSCA Interagency Agency, 401 M Street, SW., Rm. E± Electronic comments can be sent Testing Committee (ITC), established 543B, Washington, DC 20460, (202) directly to EPA at: under section 4(e) of the Toxic 554±1404, TDD (202) 554±0551, [email protected] Substances Control Act (TSCA), Internet: TSCA- transmitted its Thirty-Sixth Report to [email protected].
    [Show full text]
  • Chapter 21 the Chemistry of Carboxylic Acid Derivatives
    Instructor Supplemental Solutions to Problems © 2010 Roberts and Company Publishers Chapter 21 The Chemistry of Carboxylic Acid Derivatives Solutions to In-Text Problems 21.1 (b) (d) (e) (h) 21.2 (a) butanenitrile (common: butyronitrile) (c) isopentyl 3-methylbutanoate (common: isoamyl isovalerate) The isoamyl group is the same as an isopentyl or 3-methylbutyl group: (d) N,N-dimethylbenzamide 21.3 The E and Z conformations of N-acetylproline: 21.5 As shown by the data above the problem, a carboxylic acid has a higher boiling point than an ester because it can both donate and accept hydrogen bonds within its liquid state; hydrogen bonding does not occur in the ester. Consequently, pentanoic acid (valeric acid) has a higher boiling point than methyl butanoate. Here are the actual data: INSTRUCTOR SUPPLEMENTAL SOLUTIONS TO PROBLEMS • CHAPTER 21 2 21.7 (a) The carbonyl absorption of the ester occurs at higher frequency, and only the carboxylic acid has the characteristic strong, broad O—H stretching absorption in 2400–3600 cm–1 region. (d) In N-methylpropanamide, the N-methyl group is a doublet at about d 3. N-Ethylacetamide has no doublet resonances. In N-methylpropanamide, the a-protons are a quartet near d 2.5. In N-ethylacetamide, the a- protons are a singlet at d 2. The NMR spectrum of N-methylpropanamide has no singlets. 21.9 (a) The first ester is more basic because its conjugate acid is stabilized not only by resonance interaction with the ester oxygen, but also by resonance interaction with the double bond; that is, the conjugate acid of the first ester has one more important resonance structure than the conjugate acid of the second.
    [Show full text]
  • Dipropylene Glycol Ethyl Ether (DPGEE) [Ethyl DIPROXITOL] Product Stewardship Summary December 2017
    DiPropylene Glycol Ethyl Ether (DPGEE) [Ethyl DIPROXITOL] Product Stewardship Summary December 2017 DiPropylene Glycol Ethyl Ether (DPGEE) [Ethyl DIPROXITOL] Product Stewardship Summary (CAS number 30025-38-8) Chemical Formula for DPGEE C8H18 O3 What is DPGEE? DPGEE is a glycol ether based on Propylene oxide and ethanol. It is a speciality solvent having a bi- functional nature (ether-alcohol). It is a clear liquid with an ethereal odour. The Shell Chemicals range of Propylene oxide-based glycol ethers are sold under the trade name PROXITOL. How is DPGEE Used? It is used as an intermediate and in formulations in industrial, professional or consumer applications, mainly in surface coatings and printing inks and paints, cleaners, agrochemical or de-icing/anti-icing formulations. Health, Safety and Environmental Considerations DPGEE is flammable liquids with a flashpoint of 180 0F/82 0C. DPGEE is an isomer mix, of which the main component is 1-Ethoxypropanol-2 (typically 98% or more). Shell PROXITOLs are not classified as carcinogens or mutagens, are not expected to cause cancer in humans, nor do they impair fertility or damage the developing foetus. DPGEE is of low toxicity towards aquatic organisms. They are completely miscible with water, biodegradable and not expected to bio-accumulate. Storing and Transporting DPGEE DPGEE is transported by tank truck, rail car and vessel, primarily in bulk quantities, but also as packed product. Due to its flammability, they are classified as hazardous for transport under transport regulations. Glycol Ethers should be stored at ambient temperatures away from sources of ignition and substances with oxidising or corrosive properties.
    [Show full text]
  • Common and Chemical Names of Herbicides Approved by the WSSA
    Weed Science 2010 58:511–518 Common and Chemical Names of Herbicides Approved by the Weed Science Society of America Below is the complete list of all common and chemical of herbicides as approved by the International Organization names of herbicides approved by the Weed Science Society of for Standardization (ISO). A sponsor may submit a proposal America (WSSA) and updated as of September 1, 2010. for a common name directly to the WSSA Terminology Beginning in 1996, it has been published yearly in the last Committee. issue of Weed Science with Directions for Contributors to A herbicide common name is not synonymous with Weed Science. This list is published in lieu of the selections a commercial formulation of the same herbicide, and in printed previously on the back cover of Weed Science. Only many instances, is not synonymous with the active ingredient common and chemical names included in this complete of a commercial formulation as identified on the product list should be used in WSSA publications. In the absence of label. If the herbicide is a salt or simple ester of a parent a WSSA-approved common name, the industry code number compound, the WSSA common name applies to the parent as compiled by the Chemical Abstracts Service (CAS) with compound only. CAS systematic chemical name or the systematic chemical The chemical name used in this list is that preferred by the name alone may be used. The current approved list is also Chemical Abstracts Service (CAS) according to their system of available at our web site (www.wssa.net).
    [Show full text]
  • Transport of Dangerous Goods
    ST/SG/AC.10/1/Rev.16 (Vol.I) Recommendations on the TRANSPORT OF DANGEROUS GOODS Model Regulations Volume I Sixteenth revised edition UNITED NATIONS New York and Geneva, 2009 NOTE The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the Secretariat of the United Nations concerning the legal status of any country, territory, city or area, or of its authorities, or concerning the delimitation of its frontiers or boundaries. ST/SG/AC.10/1/Rev.16 (Vol.I) Copyright © United Nations, 2009 All rights reserved. No part of this publication may, for sales purposes, be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, electrostatic, magnetic tape, mechanical, photocopying or otherwise, without prior permission in writing from the United Nations. UNITED NATIONS Sales No. E.09.VIII.2 ISBN 978-92-1-139136-7 (complete set of two volumes) ISSN 1014-5753 Volumes I and II not to be sold separately FOREWORD The Recommendations on the Transport of Dangerous Goods are addressed to governments and to the international organizations concerned with safety in the transport of dangerous goods. The first version, prepared by the United Nations Economic and Social Council's Committee of Experts on the Transport of Dangerous Goods, was published in 1956 (ST/ECA/43-E/CN.2/170). In response to developments in technology and the changing needs of users, they have been regularly amended and updated at succeeding sessions of the Committee of Experts pursuant to Resolution 645 G (XXIII) of 26 April 1957 of the Economic and Social Council and subsequent resolutions.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 8,552,057 B2 Brinton Et Al
    US008552057B2 (12) United States Patent (10) Patent No.: US 8,552,057 B2 Brinton et al. (45) Date of Patent: *Oct. 8, 2013 (54) PHYTOESTROGENIC FORMULATIONS FOR OTHER PUBLICATIONS ALLEVATION OR PREVENTION OF Morito et al. Interaction of Phytoestrogens with Estrogen Receptors NEURODEGENERATIVE DISEASES a and b (II). Biol. Pharm. Bull. 25(1), pp. 48-52 (2002).* Kinjo et al. Interactions of Phytoestrogens with Estrogen Receptors a (75) Inventors: Roberta Diaz, Brinton, Rancho Palos and b (III). Biol. Pharm. Bull. 27(2) pp. 185-188 (2004).* Verdes, CA (US); Liqin Zhao, Los An, et al., "Estrogen receptor -selective transcriptional activity and Angeles, CA (US) recruitment of coregulators by phytoestrogens', J Biol. Chem. 276(21): 17808-14 (2001). (73) Assignee: University of Southern California, Los Avis, et al. Is there a menopausal syndrome'? Menopausal status and symptoms across racial/ethnic groups', Soc. Sci. Med., 52(3):345-56 Angeles, CA (US) (2001). Brinton, et al. Impact of estrogen therapy on Alzheimer's disease: a (*) Notice: Subject to any disclaimer, the term of this fork in the road?’ CNS Drugs, 18(7):405-422 (2004). patent is extended or adjusted under 35 Bromberger, et al., Psychologic distress and natural menopause: a U.S.C. 154(b) by 0 days. multiethnic community study’. Am. J. Public Health, 91 (9) 1435-42 (2001). This patent is Subject to a terminal dis Brookmeyer, et al., “Projections of Alzheimer's disease in the United claimer. States and the public health impact of delaying disease onset'. Am. J. Public Health, 88(9): 1337-42 (1998). (21) Appl.
    [Show full text]
  • Herbicide Mode of Action Table High Resistance Risk
    Herbicide Mode of Action Table High resistance risk Chemical family Active constituent (first registered trade name) GROUP 1 Inhibition of acetyl co-enzyme A carboxylase (ACC’ase inhibitors) clodinafop (Topik®), cyhalofop (Agixa®*, Barnstorm®), diclofop (Cheetah® Gold* Decision®*, Hoegrass®), Aryloxyphenoxy- fenoxaprop (Cheetah®, Gold*, Wildcat®), fluazifop propionates (FOPs) (Fusilade®), haloxyfop (Verdict®), propaquizafop (Shogun®), quizalofop (Targa®) Cyclohexanediones (DIMs) butroxydim (Factor®*), clethodim (Select®), profoxydim (Aura®), sethoxydim (Cheetah® Gold*, Decision®*), tralkoxydim (Achieve®) Phenylpyrazoles (DENs) pinoxaden (Axial®) GROUP 2 Inhibition of acetolactate synthase (ALS inhibitors), acetohydroxyacid synthase (AHAS) Imidazolinones (IMIs) imazamox (Intervix®*, Raptor®), imazapic (Bobcat I-Maxx®*, Flame®, Midas®*, OnDuty®*), imazapyr (Arsenal Xpress®*, Intervix®*, Lightning®*, Midas®* OnDuty®*), imazethapyr (Lightning®*, Spinnaker®) Pyrimidinyl–thio- bispyribac (Nominee®), pyrithiobac (Staple®) benzoates Sulfonylureas (SUs) azimsulfuron (Gulliver®), bensulfuron (Londax®), chlorsulfuron (Glean®), ethoxysulfuron (Hero®), foramsulfuron (Tribute®), halosulfuron (Sempra®), iodosulfuron (Hussar®), mesosulfuron (Atlantis®), metsulfuron (Ally®, Harmony®* M, Stinger®*, Trounce®*, Ultimate Brushweed®* Herbicide), prosulfuron (Casper®*), rimsulfuron (Titus®), sulfometuron (Oust®, Eucmix Pre Plant®*, Trimac Plus®*), sulfosulfuron (Monza®), thifensulfuron (Harmony®* M), triasulfuron (Logran®, Logran® B-Power®*), tribenuron (Express®),
    [Show full text]
  • TRP Mediation
    molecules Review Remedia Sternutatoria over the Centuries: TRP Mediation Lujain Aloum 1 , Eman Alefishat 1,2,3 , Janah Shaya 4 and Georg A. Petroianu 1,* 1 Department of Pharmacology, College of Medicine and Health Sciences, Khalifa University of Science and Technology, Abu Dhabi 127788, United Arab Emirates; [email protected] (L.A.); Eman.alefi[email protected] (E.A.) 2 Center for Biotechnology, Khalifa University of Science and Technology, Abu Dhabi 127788, United Arab Emirates 3 Department of Biopharmaceutics and Clinical Pharmacy, Faculty of Pharmacy, The University of Jordan, Amman 11941, Jordan 4 Pre-Medicine Bridge Program, College of Medicine and Health Sciences, Khalifa University of Science and Technology, Abu Dhabi 127788, United Arab Emirates; [email protected] * Correspondence: [email protected]; Tel.: +971-50-413-4525 Abstract: Sneezing (sternutatio) is a poorly understood polysynaptic physiologic reflex phenomenon. Sneezing has exerted a strange fascination on humans throughout history, and induced sneezing was widely used by physicians for therapeutic purposes, on the assumption that sneezing eliminates noxious factors from the body, mainly from the head. The present contribution examines the various mixtures used for inducing sneezes (remedia sternutatoria) over the centuries. The majority of the constituents of the sneeze-inducing remedies are modulators of transient receptor potential (TRP) channels. The TRP channel superfamily consists of large heterogeneous groups of channels that play numerous physiological roles such as thermosensation, chemosensation, osmosensation and mechanosensation. Sneezing is associated with the activation of the wasabi receptor, (TRPA1), typical ligand is allyl isothiocyanate and the hot chili pepper receptor, (TRPV1), typical agonist is capsaicin, in the vagal sensory nerve terminals, activated by noxious stimulants.
    [Show full text]
  • Targeting Angiogenesis by Phytochemicals
    Arom & at al ic in P l ic a n d t Kadioglu et al., Med Aromat Plants 2013, 2:5 e s M Medicinal & Aromatic Plants DOI: 10.4172/2167-0412.1000134 ISSN: 2167-0412 ResearchReview Article Article OpenOpen Access Access Targeting Angiogenesis By Phytochemicals Onat Kadioglu, Ean Jeong Seo and Thomas Efferth* Department of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry, Johannes Gutenberg University, Staudinger Weg 5, 55128 Mainz, Germany Abstract Cancer is a major cause of death worldwide and angiogenesis is critical in cancer progression. Development of new blood vessels and nutrition of tumor cells are heavily dependent on angiogenesis. Thus, angiogenesis inhibition might be a promising approach for anticancer therapy. Anti-angiogenic small molecule and phytochemicals as a cancer treatment approach are focused in these main points; modes of action, adverse effects, mechanisms of resistance and new developments. Treatment with anti-angiogenic compounds might be advantageous over conventional chemotherapy due to the fact that those compounds mainly act on endothelial cells, which are genetically more stable and homogenous compared to tumor cells and they show lower susceptibility to acquired drug resistance (ADR). Targeting the VEGF (vascular endothelial growth factor) signalling pathway with synthetic small molecules inhibiting Receptor Tyrosine Kinases (RTKs) in addition to antagonizing VEGF might be a promising approach. Moreover, beneficial effect of phytochemicals were proven on cancer-related pathways especially concerning anti-angiogenesis. Plant phenolics being an important category of prominent phytochemicals affect different pathways of angiogenesis. Green tea polyphenols (epigallocatechin gallate) and soy bean isoflavones (genistein) are two examples involving an anti-angiogenic effect.
    [Show full text]
  • The Reactivity of Human and Equine Estrogen Quinones Towards Purine Nucleosides
    S S symmetry Article The Reactivity of Human and Equine Estrogen Quinones towards Purine Nucleosides Zsolt Benedek †, Peter Girnt † and Julianna Olah * Department of Inorganic and Analytical Chemistry, Budapest University of Technology and Economics, Szent Gellért tér 4, H-1111 Budapest, Hungary; [email protected] (Z.B.); [email protected] (P.G.) * Correspondence: [email protected] † These authors contributed equally to this work. Abstract: Conjugated estrogen medicines, which are produced from the urine of pregnant mares for the purpose of menopausal hormone replacement therapy (HRT), contain the sulfate conjugates of estrone, equilin, and equilenin in varying proportions. The latter three steroid sex hormones are highly similar in molecular structure as they only differ in the degree of unsaturation of the sterane ring “B”: the cyclohexene ring in estrone (which is naturally present in both humans and horses) is replaced by more symmetrical cyclohexadiene and benzene rings in the horse-specific (“equine”) hormones equilin and equilenin, respectively. Though the structure of ring “B” has only moderate influence on the estrogenic activity desired in HRT, it might still significantly affect the reactivity in potential carcinogenic pathways. In the present theoretical study, we focus on the interaction of estrogen orthoquinones, formed upon metabolic oxidation of estrogens in breast cells with purine nucleosides. This multistep process results in a purine base loss in the DNA chain (depurination) and the formation of a “depurinating adduct” from the quinone and the base. The point mutations induced in this manner are suggested to manifest in breast cancer development in the long run.
    [Show full text]
  • Supplementary Information
    Supplementary Information Network-based Drug Repurposing for Novel Coronavirus 2019-nCoV Yadi Zhou1,#, Yuan Hou1,#, Jiayu Shen1, Yin Huang1, William Martin1, Feixiong Cheng1-3,* 1Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA 2Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH 44195, USA 3Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA #Equal contribution *Correspondence to: Feixiong Cheng, PhD Lerner Research Institute Cleveland Clinic Tel: +1-216-444-7654; Fax: +1-216-636-0009 Email: [email protected] Supplementary Table S1. Genome information of 15 coronaviruses used for phylogenetic analyses. Supplementary Table S2. Protein sequence identities across 5 protein regions in 15 coronaviruses. Supplementary Table S3. HCoV-associated host proteins with references. Supplementary Table S4. Repurposable drugs predicted by network-based approaches. Supplementary Table S5. Network proximity results for 2,938 drugs against pan-human coronavirus (CoV) and individual CoVs. Supplementary Table S6. Network-predicted drug combinations for all the drug pairs from the top 16 high-confidence repurposable drugs. 1 Supplementary Table S1. Genome information of 15 coronaviruses used for phylogenetic analyses. GenBank ID Coronavirus Identity % Host Location discovered MN908947 2019-nCoV[Wuhan-Hu-1] 100 Human China MN938384 2019-nCoV[HKU-SZ-002a] 99.99 Human China MN975262
    [Show full text]
  • Targeting Multidrug Resistance Proteins and C-Type Natriuretic Peptide to Optimise Cyclic GMP Signalling in Cardiovascular Disease
    Targeting multidrug resistance proteins and C-type natriuretic peptide to optimise cyclic GMP signalling in cardiovascular disease Robert Matthew Henry Grange Submitted in partial fulfilment of the requirements of the Degree of Doctor of Philosophy Heart Centre William Harvey Research Institute Barts & The London School of Medicine & Dentistry Queen Mary University of London Charterhouse Square London EC1M 6BQ United Kingdom STATEMENT OF ORIGINALITY I, Robert Matthew Henry Grange, confirm that the research included within this thesis is my own work or that where it has been carried out in collaboration with, or supported by others, that this is duly acknowledged below and my contribution indicated. Previously published material is also acknowledged below. I attest that I have exercised reasonable care to ensure that the work is original, and does not to the best of my knowledge break any UK law, infringe any third party’s copyright or other Intellectual Property Right, or contain any confidential material. I accept that the College has the right to use plagiarism detection software to check the electronic version of the thesis. I confirm that this thesis has not been previously submitted for the award of a degree by this or any other university. The copyright of this thesis rests with the author and no quotation from it or information derived from it may be published without the prior written consent of the author. Signature: Date: 05/05/2016 I PUBLISHED ABSTRACTS Allen RMH, Renukanthan A, Bubb KJ, Villar IC, Moyes AJ, Baliga RS, Hobbs AJ. Investigation of the role of multidrug resistance proteins (MRPs) in vascular homeostasis.
    [Show full text]